Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
about
Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysisOmega-3 fatty acids for the treatment of dementiaOmega-3 fatty acids: potential role in the management of early Alzheimer's diseaseExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful agingBiomarkers of oxidative damage and inflammation in Alzheimer's disease.Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Omega-3 fatty acids EPA and DHA: health benefits throughout life.Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity.Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.Epidemiology of Alzheimer disease.Nutrient intake and plasma β-amyloid.Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.(N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.Cytokine Therapies in Neurological Disease.APP Function and Lipids: A Bidirectional Link.DHA may prevent age-related dementia.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Current therapies and new strategies for the management of Alzheimer's disease.Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials.Nutrition and brain aging: how can we move ahead?Role of fish oil in human health and possible mechanism to reduce the inflammation.Dietary DHA and health: cognitive function ageing.Is there a causal link between inflammation and dementia?Targeting Neuroinflammation to Treat Alzheimer's Disease.Impact of dietary fats on brain functions.Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention.Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.Food for thought: how nutrition impacts cognition and emotion
P2860
Q21132327-E055C465-BDE9-41BB-B57D-B57C4024B397Q24185910-486A0B41-6444-4350-8EEB-C78BE36C019CQ24595490-287B59CA-1F63-4D1D-A674-C551C3C9DA8AQ27021694-81B089CD-8B92-495D-948F-1BF14A9DFE29Q28730725-033387B0-451A-44CF-BBA1-92D626D273A8Q33771834-7122645F-92F9-42ED-AE62-12253C8EE522Q34330929-9AB123AD-70E6-4C7F-BF20-E18334DF9BDDQ34408888-BD80C112-9678-4E96-BBF0-58B74A178EFEQ34635830-5FFDDFEE-686A-468F-A36F-043861705540Q34777760-77E5B31E-C618-40D0-BA09-55AEC13B1C5DQ35542811-068DB5EE-1A1D-4662-9FF1-8E1DB1D819E9Q35885375-A5C74B2E-3DEB-4704-91AD-0558D658EB06Q35920548-2F6340AD-D17B-4AE2-AC19-4AC09DCE92ECQ36014708-C356CF11-34DC-4E37-9226-ABA23FB158F5Q36457368-FF7FC927-622B-47BF-9655-50375C076224Q36830364-665B149C-F8BD-4CEE-8DBB-3CDF55D31298Q37136498-0B54051B-69C4-4540-ADDD-9D2D95A84753Q37692220-F2CF31A7-55FC-4062-947C-C4C3F2D90786Q37698014-BE672452-88EC-483B-8762-EFDE7EA2EDA3Q37703299-6F6FDA49-D6F3-42AF-A04E-389FE16A15CCQ37770005-F5A824A8-9A03-46CB-A6AE-A0D80AB1C8E6Q38010556-395F955D-44DB-4E29-93EE-5833660847A4Q38243598-8371E4B8-104D-4B80-869C-78E47640ED28Q38353525-61B84CFE-5FA6-4A77-B30B-EF3E43CF207DQ39014590-4AC02131-038C-4255-8CB8-81A225EEEC29Q39387457-14517811-59B4-4FCA-9F36-929AFA2E0967Q47188911-072D92A8-186B-423E-9367-9369513FAFF8Q47290017-3E178AF5-5C22-4E7A-A12D-FF3DF1A2215CQ47815645-43F29CA5-BF21-41DA-92A8-55B8F0ABEC24Q52879007-C3C15C13-D5F7-4757-8862-51B5D8DF7786Q53347902-274A9C6F-DC7E-4C9F-AB3F-79C60CEFBA81Q59118186-28D2ABF0-18B5-49B9-9E20-FFDFF7AB2CC3
P2860
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@en
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@nl
type
label
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@en
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@nl
prefLabel
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@en
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@nl
P2093
P50
P921
P356
P1476
Effects of omega-3 fatty acids ...... r's disease: the OmegAD study.
@en
P2093
Catharina Lindberg
Erik Hjorth
Gerd Faxen-Irving
Hans Basun
Inger Vedin
Tommy Cederholm
P304
P356
10.1159/000218081
P577
2009-05-12T00:00:00Z